Discover: How Emerging Biopharma Companies can Protect Culture and Engagement Through M&A Integration
9:10 am - Wednesday 9th December 2026
- How can acquired biotechs and their new parent company protect innovation, engagement and critical talent through the highest risk period of integration?
- Learn how Roche’s M&A team manages the full arc of a deal, from due diligence through integration, with a particular focus on employee experience as the factor that determines whether an acquisition ultimately succeeds
- Discover the practical tools used to keep teams engaged and productive through cultural and structural change, including how Roche balances global consistency with the realities of function and site level culture
